Consecutive Inhibition of Telomerase and Alternative Lengthening Pathway Promotes Hodgkin's Lymphoma Cell Death.

Lima, Matheus Fabiao de; Freitas, Monique Oliveira; Hamedani, Mohammad K; Rangel-Pozzo, Aline; Zhu, Xu-Dong; Mai, Sabine

Lima, Matheus Fabiao de; Freitas, Monique Oliveira; Hamedani, Mohammad K; Rangel-Pozzo, Aline; Zhu, Xu-Dong; Mai, Sabine.

Afiliação

Lima MF; Department of Physiology and Pathophysiology, CancerCare Manitoba Research Institute, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Freitas MO; Genetic Service, Institute of Paediatrics and Puericulture Martagão Gesteira (IPPMG), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941-912, Brazil.
Hamedani MK; Department of Physiology and Pathophysiology, CancerCare Manitoba Research Institute, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Rangel-Pozzo A; Department of Physiology and Pathophysiology, CancerCare Manitoba Research Institute, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Zhu XD; Department of Biology, Faculty of Science, McMaster University, Hamilton, ON L8S 4K1, Canada.
Mai S; Department of Physiology and Pathophysiology, CancerCare Manitoba Research Institute, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.

Biomedicines ; 10(9)2022 Sep 16.

Article em En | MEDLINE | ID: mdl-36140400

Palavras-chave

BIBR 1532; alternative lengthening of telomeres (ALT); promyelocytic leukemia bodies (PML); telomerase; telomeric repeat-binding factor 1 (TRF1); trabectedin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google